Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

A “complement–ary” AIDS vaccine

Nature Medicine volume 2, pages 153–155 (1996)Cite this article

The human immunodeficiency virus uses the human complement system to its advantage. Is it possible to turn the tables with a vaccine?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Atkinson, J.P., Odlesby, T.J., White, D.J.G., Adams, E.A. & Liszewski, M.K. Separation of self from non-self in the complement system. A role for membrane cofactor protein and decay accelerating factor. Clin. Exp. Immun. 86, 27–30 (1991).

    Article  CAS  Google Scholar 

  2. Bach, F.H. et al. Barriers to xenotransplantation. Nature Med. 1, 869–873 (1995).

    Article  CAS  Google Scholar 

  3. Cozzi, E. & White, D.J.G. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1, 964–966 (1995).

    Article  CAS  Google Scholar 

  4. Dierich, M.P. et al. HIV and human complement: Mechanisms of interaction and biological implications. Immunol. Today 14, 435–440 (1993).

    Article  CAS  Google Scholar 

  5. Stoiber, H., Pinter, C., Siccardi, A.G., Clivio, A. & Dierich, M.P. Efficient destruction of HIV in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med. (in the press).

  6. Marschang, P., Sodroski, J., Würzner, R. & Dierich, M.P. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur. J. Immunol. 25, 285–290 (1995).

    Article  CAS  Google Scholar 

  7. Saifuddin, M. et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell-line derived and primary isolates of HIV 1. J. Exp. Med. 182, 501–509 (1995).

    Article  CAS  Google Scholar 

  8. Gelderblom, H.R. Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS 5, 617–637 (1991).

    Article  CAS  Google Scholar 

  9. Arthur, L.O. et al. Cellular proteins bound to immunodeficiency viruses: implication for pathogenesis and vaccines. Science 258, 1935–1938 (1992).

    Article  CAS  Google Scholar 

  10. Orentas, R.J. & Hildreth, J.E.K. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retrovir. 9, 1157–1165 (1993).

    Article  CAS  Google Scholar 

  11. Morgan, B.P. & Meri, S. Membrane proteins that protect against complement lysis. Immuno-pathology 15, 369–396 (1994).

    CAS  Google Scholar 

  12. Ebenbichler, C., Thielens, N., Arlaud, G. & Dierich, M.P. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174, 944–952 (1991).

    Article  Google Scholar 

  13. Stoiber, H., Thielens, N., Ebenbichler, C., Arlaud, G. & Dierich, M.P. The envelope glycoprotein of HIV-1 gp120 and the human complement protein Clq bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenetic homology. Eur. J. Immunol. 24, 294–300 (1994).

    Article  CAS  Google Scholar 

  14. Sölder, B.M. et al. Complement receptors: Another port of entry for HIV. Lancet ii, 271–272 (1989).

    Article  Google Scholar 

  15. Reisinger, E. et al. Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937. AIDS 4, 961–965 (1989).

    Article  Google Scholar 

  16. Tremblay, M.S., Meloche, S., Sekaly, R.P. & Wainberg, M.A.J. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus carrying B cells. Exp. Med. 171, 1791–1796 (1990).

    Article  CAS  Google Scholar 

  17. Boyer, V., Desgranges, C., Trabaud, M.A., Fischer, E. & Kazatchkine, M.D. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4-and antibody-independent fashion. J. Exp. Med. 173, 1151–1158 (1991).

    Article  CAS  Google Scholar 

  18. Robinson, E.W., Montefiori, D.C. & Mitchell, W.M. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175, 600–604 (1990).

    Article  CAS  Google Scholar 

  19. Joling, P. et al. Binding of human immunodeficiency virus type 1 to follicular dendritic cells in vitro is complement dependent. J. Immunol. 150, 1065–1073 (1993).

    CAS  PubMed  Google Scholar 

  20. Pintér, C., Siccardi, A.G., Longhi, R. & Clivio, A. Direct interaction of complement factor H with the C1 domain of HIV-1 gp120. AIDS Res. Hum. Retrovir. 11, 577–588 (1995).

    Article  Google Scholar 

  21. Stoiber, H., Ebenbichler, C., Schneider, R., Janatova, J. & Dierich, M.P. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 9, 19–26 (1995).

    Article  CAS  Google Scholar 

  22. Pintér, C., Siccardi, A.G., Lopalco, L., Longhi, R. & Clivio, A. HIV gp41 and complement factor H interact with each other and share functional as well as antigenic homology. AIDS Res. Hum. Retrovir. 11, 971–980 (1995).

    Article  Google Scholar 

  23. Stoiber, H., Schneider, R., Janatova, J. & Dierich, M.P. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology 193, 98–113 (1995).

    Article  CAS  Google Scholar 

  24. Morgan, B.P. & Walport, M.J. Complement deficiency and diseases. Immunol. Today 12, 301–306 (1991).

    Article  CAS  Google Scholar 

  25. Kinoshita, T. Biology of complement: The overture. Immunol. Today 12, 291–295 (1991).

    Article  CAS  Google Scholar 

  26. Bhakdi, S. & Tranum-Jensen, J. Complement lysis: A hole is a hole. Immunol. Today 12, 318–320 (1991).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Hygiene and Ludwig, Boltzmann-Institut für AIDS-Forschung, Innsbruck, Austria

    Manfred P. Dierich & Heribert Stoiber

  2. Laboratorio Interdisciplinare Tecnologie Avanzate, Universit egli Studi di Milano, Italy

    Alberto Clivio

Authors
  1. Manfred P. Dierich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heribert Stoiber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto Clivio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dierich, M., Stoiber, H. & Clivio, A. A “complement–ary” AIDS vaccine. Nat Med 2, 153–155 (1996). https://doi.org/10.1038/nm0296-153

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0296-153

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing